Reversible neurotoxicity during interleukin-2 therapy for metastatic renal cell carcinoma
- 1 October 1995
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (11) , 1895-1897
- https://doi.org/10.1016/0959-8049(95)00297-v
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Multifocal neurotoxicity during interleukin-2 therapy for malignant melanomaClinical Oncology, 1992
- Neurological ischemic attack and interleukin-2 therapy.Stroke, 1991
- Interleukin-2 toxicity.Journal of Clinical Oncology, 1991
- Acute Fatal Leukoencephalopathy after Interleukin-2 TherapyNew England Journal of Medicine, 1990
- Interleultin‐2 treatment‐associated eosinophilia is mediated by interleultin‐5 productionBritish Journal of Haematology, 1990
- Eosinophilic myocarditis associated with high-dose interleukin-2 therapyThe American Journal of Medicine, 1990
- The appearance of hypodense eosinophils during interleukin-2 treatmentJournal of Allergy and Clinical Immunology, 1990
- Transient focal neurologic deficits complicating interleukin‐2 therapyNeurology, 1990
- Clinical toxicity of interferons in cancer patients: a review.Journal of Clinical Oncology, 1986